Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Prediction of clinical pharmacokinetics of AMG 181, a human anti-α 4 β 7 monoclonal antibody for treating inflammatory bowel diseases.

Li H, Köck K, Wisler JA, Rees WA, Prince PJ, Reynhardt KO, Hsu H, Yu Z, Borie DC, Salinger DH, Pan WJ.

Pharmacol Res Perspect. 2015 Feb;3(1):e00098. doi: 10.1002/prp2.98. Epub 2014 Dec 9.

2.

Clinical pharmacology of AMG 181, a gut-specific human anti-α4β7 monoclonal antibody, for treating inflammatory bowel diseases.

Pan WJ, Köck K, Rees WA, Sullivan BA, Evangelista CM, Yen M, Andrews JM, Radford-Smith GL, Prince PJ, Reynhardt KO, Doherty DR, Patel SK, Krill CD, Zhou K, Shen J, Smith LE, Gow JM, Lee J, Treacy AM, Yu Z, Platt VM, Borie DC.

Br J Clin Pharmacol. 2014 Dec;78(6):1315-33. doi: 10.1111/bcp.12418.

3.

Pharmacology of AMG 181, a human anti-α4 β7 antibody that specifically alters trafficking of gut-homing T cells.

Pan WJ, Hsu H, Rees WA, Lear SP, Lee F, Foltz IN, Rathanaswami P, Manchulenko K, Chan BM, Zhang M, Xia XZ, Patel SK, Prince PJ, Doherty DR, Sheckler CM, Reynhardt KO, Krill CD, Harder BJ, Wisler JA, Brandvig JL, Lynch JL, Anderson AA, Wienkers LC, Borie DC.

Br J Pharmacol. 2013 May;169(1):51-68. doi: 10.1111/bph.12134.

4.

Janus kinase 3 inhibition with CP-690,550 prevents allograft vasculopathy.

Rousvoal G, Si MS, Lau M, Zhang S, Berry GJ, Flores MG, Changelian PS, Reitz BA, Borie DC.

Transpl Int. 2006 Dec;19(12):1014-21.

5.

Similarities in the immunoglobulin response and VH gene usage in rhesus monkeys and humans exposed to porcine hepatocytes.

Zahorsky-Reeves JL, Gregory CR, Cramer DV, Patanwala IY, Kyles AE, Borie DC, Kearns-Jonker MK.

BMC Immunol. 2006 Mar 20;7:3.

6.

Combined use of the JAK3 inhibitor CP-690,550 with mycophenolate mofetil to prevent kidney allograft rejection in nonhuman primates.

Borie DC, Larson MJ, Flores MG, Campbell A, Rousvoal G, Zhang S, Higgins JP, Ball DJ, Kudlacz EM, Brissette WH, Elliott EA, Reitz BA, Changelian PS.

Transplantation. 2005 Dec 27;80(12):1756-64.

PMID:
16378072
7.

Effects of JAK3 inhibition with CP-690,550 on immune cell populations and their functions in nonhuman primate recipients of kidney allografts.

Paniagua R, Si MS, Flores MG, Rousvoal G, Zhang S, Aalami O, Campbell A, Changelian PS, Reitz BA, Borie DC.

Transplantation. 2005 Nov 15;80(9):1283-92.

PMID:
16314797
8.

Quantitative analysis of the immunosuppressant CP-690,550 in whole blood by column-switching high-performance liquid chromatography and mass spectrometry detection.

Paniagua R, Campbell A, Changelian PS, Reitz BA, Prakash C, Borie DC.

Ther Drug Monit. 2005 Oct;27(5):608-16.

PMID:
16175134
9.

Immunosuppressive effects of surgery assessed by flow cytometry in nonhuman primates after nephrectomy.

Stalder M, Bîrsan T, Hausen B, Borie DC, Morris RE.

Transpl Int. 2005 Oct;18(10):1158-65.

10.

Identification of the V genes encoding xenoantibodies in non-immunosuppressed rhesus monkeys.

Kleihauer A, Gregory CR, Borie DC, Kyles AE, Shulkin I, Patanwala I, Zahorsky-Reeves J, Starnes VA, Mullen Y, Todorov IT, Kearns-Jonker M.

Immunology. 2005 Sep;116(1):89-102.

11.

Appraisal of the extent of chronic allograft vasculopathy in animal models: proposition of a standardized micromorphometric method.

Rousvoal G, Rousseau MA, Flores MG, Borie DC.

Atherosclerosis. 2005 Aug;181(2):407-9.

PMID:
15998518
12.

Use of echocardiography to assess function of hDAF-transgenic pig cardiac xenografts.

Chan MC, Stalder M, Lam TT, Tye T, Borie DC, Morris RE.

Transplant Proc. 2005 May;37(4):1923-5.

PMID:
15919505
13.

Effects of the kinase inhibitor CGP41251 (PKC 412) on lymphocyte activation and TNF-alpha production.

Si MS, Reitz BA, Borie DC.

Int Immunopharmacol. 2005 Jul;5(7-8):1141-9. Epub 2005 Mar 18.

PMID:
15914319
14.

A technique of bone marrow collection from vertebral bodies of cynomolgus macaques for transplant studies.

Flores MG, Holm B, Larson MJ, Lau MK, Si MS, Lowsky R, Rousvoal G, Grumet FC, Strober S, Hoppe R, Reitz BA, Borie DC.

J Surg Res. 2005 Apr;124(2):280-8.

PMID:
15820259
15.

Immunosuppression by the JAK3 inhibitor CP-690,550 delays rejection and significantly prolongs kidney allograft survival in nonhuman primates.

Borie DC, Changelian PS, Larson MJ, Si MS, Paniagua R, Higgins JP, Holm B, Campbell A, Lau M, Zhang S, Flores MG, Rousvoal G, Hawkins J, Ball DA, Kudlacz EM, Brissette WH, Elliott EA, Reitz BA, Morris RE.

Transplantation. 2005 Apr 15;79(7):791-801.

PMID:
15818321
16.

Improved assessment of graft function by echocardiography in cynomolgus monkey recipients of hDAF-transgenic pig cardiac xenografts.

Stalder M, Tye T, Lam TT, Chan MC, Berry GJ, Borie DC, Morris RE.

J Heart Lung Transplant. 2005 Feb;24(2):215-21.

PMID:
15701440
17.

Outbreak of Mycobacterium bovis in a conditioned colony of rhesus (Macaca mulatta) and cynomolgus (Macaca fascicularis) macaques.

Garcia MA, Bouley DM, Larson MJ, Lifland B, Moorhead R, Simkins MD, Borie DC, Tolwani R, Otto G.

Comp Med. 2004 Oct;54(5):578-84.

PMID:
15575373
18.

Inhibition of lymphocyte activation and function by the prenylation inhibitor L-778,123.

Si MS, Reitz BA, Borie DC.

Invest New Drugs. 2005 Jan;23(1):21-9.

PMID:
15528977
19.

JAK3 inhibition, a viable new modality of immunosuppression for solid organ transplants.

Borie DC, O'Shea JJ, Changelian PS.

Trends Mol Med. 2004 Nov;10(11):532-41. Review.

PMID:
15519279
20.

Anti-non-Gal porcine endothelial cell antibodies in acute humoral xenograft rejection of hDAF-transgenic porcine hearts in cynomolgus monkeys.

Lam TT, Paniagua R, Shivaram G, Schuurman HJ, Borie DC, Morris RE.

Xenotransplantation. 2004 Nov;11(6):531-5.

PMID:
15479463
21.

Compared with cyclosporine, ISATX247 significantly prolongs renal-allograft survival in a nonhuman primate model.

Gregory CR, Kyles AE, Bernsteen L, Wagner GS, Tarantal AF, Christe KL, Brignolo L, Spinner A, Griffey SM, Paniagua RT, Hubble RW, Borie DC, Morris RE.

Transplantation. 2004 Sep 15;78(5):681-5.

PMID:
15371668
22.

In vitro evaluation of the effects of candidate immunosuppressive drugs: flow cytometry and quantitative real-time PCR as two independent and correlated read-outs.

Flores MG, Zhang S, Ha A, Holm B, Reitz BA, Morris RE, Borie DC.

J Immunol Methods. 2004 Jun;289(1-2):123-35.

PMID:
15251418
23.

A new modality for immunosuppression: targeting the JAK/STAT pathway.

O'Shea JJ, Pesu M, Borie DC, Changelian PS.

Nat Rev Drug Discov. 2004 Jul;3(7):555-64. Review. No abstract available.

PMID:
15232577
24.

JAK3 inhibition as a new concept for immune suppression.

Borie DC, Si MS, Morris RE, Reitz BA, Changelian PS.

Curr Opin Investig Drugs. 2003 Nov;4(11):1297-303. Review.

PMID:
14758768
25.

Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor.

Changelian PS, Flanagan ME, Ball DJ, Kent CR, Magnuson KS, Martin WH, Rizzuti BJ, Sawyer PS, Perry BD, Brissette WH, McCurdy SP, Kudlacz EM, Conklyn MJ, Elliott EA, Koslov ER, Fisher MB, Strelevitz TJ, Yoon K, Whipple DA, Sun J, Munchhof MJ, Doty JL, Casavant JM, Blumenkopf TA, Hines M, Brown MF, Lillie BM, Subramanyam C, Shang-Poa C, Milici AJ, Beckius GE, Moyer JD, Su C, Woodworth TG, Gaweco AS, Beals CR, Littman BH, Fisher DA, Smith JF, Zagouras P, Magna HA, Saltarelli MJ, Johnson KS, Nelms LF, Des Etages SG, Hayes LS, Kawabata TT, Finco-Kent D, Baker DL, Larson M, Si MS, Paniagua R, Higgins J, Holm B, Reitz B, Zhou YJ, Morris RE, O'Shea JJ, Borie DC.

Science. 2003 Oct 31;302(5646):875-8.

26.

Immunomodulatory effects of docetaxel on human lymphocytes.

Si MS, Imagawa DK, Ji P, Wei X, Holm B, Kwok J, Lee M, Reitz BA, Borie DC.

Invest New Drugs. 2003 Aug;21(3):281-90.

PMID:
14578678
27.

Hemodynamic and hormonal responses to the sudden interruption of caval flow: insights from a prospective study of hepatic vascular exclusion during major liver resections.

Eyraud D, Richard O, Borie DC, Schaup B, Carayon A, Vézinet C, Movschin M, Vaillant JC, Coriat P, Hannoun L.

Anesth Analg. 2002 Nov;95(5):1173-8, table of contents.

PMID:
12401586
28.

Functional metabolic characteristics of intact pig livers during prolonged extracorporeal perfusion: potential for a unique biological liver-assist device.

Borie DC, Eyraud D, Boleslawski E, Lemoine A, Sebagh M, Cramer DV, Roussi J, Imbert-Bismut F, Germain G, Hannoun L.

Transplantation. 2001 Aug 15;72(3):393-405.

PMID:
11502966
29.

[Role of surgery in the treatment of refractory ascites in cirrhotic patients].

Borie DC, Vaillant JC, Breton S, Hannoun L.

Ann Chir. 1999;53(10):966-72. Review. French.

PMID:
10670142
30.
31.

Hepatectomy with hypothermic perfusion of the liver.

Vaillant JC, Borie DC, Hannoun L.

Hepatogastroenterology. 1998 Mar-Apr;45(20):381-8.

PMID:
9638411
32.

Microbiological hazards related to xenotransplantation of porcine organs into man.

Borie DC, Cramer DV, Phan-Thanh L, Vaillant JC, Bequet JL, Makowka L, Hannoun L.

Infect Control Hosp Epidemiol. 1998 May;19(5):355-65. Review.

PMID:
9613699
33.

[Immunobiology of tolerance of hepatic allografts: to what degree can the immunosuppressive treatment be avoided?].

Borie DC, Calmus Y, Boleslawski E, Hannoun L.

Gastroenterol Clin Biol. 1997;21(8-9):584-9. Review. French. No abstract available.

34.

[Vascular clamping of the liver. Indications and limits].

Borie DC, Adam R.

Ann Chir. 1997;51(6):617-26. Review. French.

PMID:
9406459
35.

The rejection of hamster xenografts by rats is mediated by a restricted repertoire of Ig heavy chain variable genes.

Cramer DV, Wu GD, Borie DC, Shirwan H, Makowka L.

Transplant Proc. 1996 Apr;28(2):569-70. No abstract available.

PMID:
8623276
36.

Germline VH gene usage in xenoreactive monoclonal antibody.

Cramer DV, Wu GD, Borie DC, Shirwan H, Miller L, Makowka L.

Transplant Proc. 1996 Apr;28(2):541-2. No abstract available.

PMID:
8623256
37.

[Xenotransplantation in man. 2: Control of rejection and application to xenotransplantation of the swine liver in man].

Borie DC, Poynard T, Hannoun L.

Gastroenterol Clin Biol. 1996;20(11):982-90. Review. French. No abstract available.

PMID:
9119188
38.

[Xenotransplantation in man. 1: Immunology of xenogenic graft rejection].

Borie DC, Poynard T, Hannoun L.

Gastroenterol Clin Biol. 1996;20(11):972-81. Review. French. No abstract available.

PMID:
9119187
39.
40.

Genetic control of the humoral immune response to xenografts. II. Monoclonal antibodies that cause rejection of heart xenografts are encoded by germline immunoglobulin genes.

Borie DC, Cramer DV, Shirwan H, Wu GD, Rodriguez O, Chapman FA, Makowka L.

Transplantation. 1995 Dec 27;60(12):1504-10.

PMID:
8545882

Supplemental Content

Loading ...
Support Center